filmov
tv
Adaptimmune
Показать описание
John Lunger, Chief Patient Supply Officer
Philadelphia, PA
(NASDAQ: ADAP)
Alliance for Regenerative Medicine
Рекомендации по теме
0:17:07
Can Adaptimmune rise 300% from here? - Company and Stock Analysis
0:27:11
Adaptimmune Therapeutics ADAP Q4 2023 Earnings Presentation
0:02:53
Adaptimmune SPEAR T-Cell Mechanism of Action Video
0:32:51
Adaptimmune Therapeutics plc (Nasdaq: ADAP): Virtual Investor Conferences
0:03:48
Manufacturing at Adaptimmune
0:03:39
Adaptimmune's allogeneic or 'off-the-shelf' cell therapies.
0:12:13
Adaptimmune
0:05:26
Adaptimmune ASGCT 2021
0:01:19
Adaptimmune Stock Breakdown: What’s Next for ADAP?
1:05:11
Update on Adaptimmune's SURPASS Family of Trials
0:13:16
Adaptimmune
2:00:38
Adaptimmune's Symposium at CTOS 2021– “Spotlight on Synovial Sarcoma; Where are we now? Where n...
0:15:06
Adaptimmune
0:14:56
Adaptimmune - Company Presentation
0:37:37
Adaptimmune Therapeutics ADAP Q2 2024 Earnings Presentation
0:17:52
Adaptimmune
0:06:02
Adaptimmune: SPEAR T-cells
0:02:17
Adaptimmune Wear White Video 2021
0:25:27
Fireside Chat with Adrian Rawcliffe, Chief Executive Officer of Adaptimmune
0:36:46
Irving Ford on Leading Adaptimmune through the FDA approval and commercialisation of Tecelra.
0:15:31
Adaptimmune
0:14:57
Adaptimmune
0:13:52
Ellen Border Perspective - World Cancer Research Day
0:13:09
Adaptimmune
0:17:07
0:27:11
0:02:53
0:32:51
0:03:48
0:03:39
0:12:13
0:05:26
0:01:19
1:05:11
0:13:16
2:00:38
0:15:06
0:14:56
0:37:37
0:17:52
0:06:02
0:02:17
0:25:27
0:36:46
0:15:31
0:14:57
0:13:52
0:13:09